CYP2E1 and hepatocellular carcinoma: The samples from HCC patients were used to evaluate the clinical value of CYP2E1 expression.<h4>Results</h4>CA treatment significantly increased the growth of HCC cells and promoted xenograft tumors accompanied by a decrease of CYP2E1 expression.